1. A perspective on arterionephrosclerosis: from pathology to potential pathogenesis. Marcantoni C, Fogo AB (2007) J Nephrol 20(5): 518-24
    › Primary publication · 17918136 (PubMed)
  2. Angiotensin inhibition decreases progression of advanced atherosclerosis and stabilizes established atherosclerotic plaques. Suganuma E, Babaev VR, Motojima M, Zuo Y, Ayabe N, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V (2007) J Am Soc Nephrol 18(8): 2311-9
    › Primary publication · 17634441 (PubMed)
  3. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse. Hahm K, Lukashev ME, Luo Y, Yang WJ, Dolinski BM, Weinreb PH, Simon KJ, Chun Wang L, Leone DR, Lobb RR, McCrann DJ, Allaire NE, Horan GS, Fogo A, Kalluri R, Shield CF, Sheppard D, Gardner HA, Violette SM (2007) Am J Pathol 170(1): 110-25
    › Primary publication · 17200187 (PubMed) · PMC1762706 (PubMed Central)
  4. Acute renal failure and myalgia in a transplant patient. Najafian B, Franklin DB, Fogo AB (2007) J Am Soc Nephrol 18(11): 2870-4
    › Primary publication · 17942960 (PubMed)
  5. Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V (2006) Atherosclerosis 184(2): 312-21
    › Primary publication · 16023123 (PubMed)
  6. The clot thickens. Fogo AB (2006) Kidney Int 70(4): 620-1
    › Primary publication · 16900220 (PubMed)
  7. Slow decline in allograft function in a renal transplant patient. Schaefer HM, Helderman JH, Fogo AB (2006) Am J Kidney Dis 48(2): 335-8
    › Primary publication · 16860203 (PubMed)
  8. Progression versus regression of chronic kidney disease. Fogo AB (2006) Nephrol Dial Transplant 21(2): 281-4
    › Primary publication · 16311260 (PubMed)
  9. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB, Ma LJ (2006) Am J Physiol Endocrinol Metab 290(1): E103-E113
    › Primary publication · 16144810 (PubMed)
  10. Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. Eddy AA, Fogo AB (2006) J Am Soc Nephrol 17(11): 2999-3012
    › Primary publication · 17035608 (PubMed)